VTR

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 1995, for Vencor, Inc. (Note: The input metadata listed "Ventas, Inc.", but the filing text explicitly identifies the registrant as Vencor, Inc.). Vencor operates an integrated network of healthcare services focused on the elderly, including hospitals, nursing centers, and ancillary services. The reporting period is significantly impacted by the consummation of the Hillhaven Merger on September 28, 1995, and the prior Nationwide Merger on June 30, 1995. These transactions were accounted for using the pooling-of-interests method, resulting in retroactive restatement of financial data to include the combined operations of all three entities.

Key Financial Metrics

Material Changes vs. Prior Period

• Nonrecurring Charges: The reported net loss for Q3 1995 was driven primarily by $128.4 million in pretax nonrecurring charges related to the Hillhaven Merger. These included $53.8 million in severance/benefits, $26.9 million in property disposition losses, $24.5 million in revenue estimate adjustments, and $23.2 million in professional fees.
• Operational Performance: Excluding nonrecurring items, income from operations increased 32% in Q3 1995 to $27.0 million and 19% for the nine-month period to $72.9 million compared to the prior year.
• Revenue Growth: Total revenues grew 10.8% in Q3 and 13.6% for the nine months. Excluding nonrecurring revenue adjustments, organic growth was approximately 16% and 15% respectively, driven by increased hospital patient days (up 27% in Q3) and subacute care volume.
• Debt Restructuring: Vencor incurred an extraordinary loss of $19.2 million (after-tax) in Q3 due to the early extinguishment of debt and refinancing activities associated with the merger.

Guidance, Outlook, and Risks

• Liquidity: Management believes cash flows from operations and the new $1 billion Credit Facility (with $348 million available at period end) are sufficient to meet future needs. Working capital improved significantly to $232.5 million.
• Capital Expenditures: Planned capital expenditures for 1995 (excluding acquisitions) are expected to approximate $150 million, financed by internal funds and the credit facility.
• Legal Contingencies: Significant litigation remains pending regarding a rejected acquisition proposal by Horizon Healthcare Corporation. This includes counterclaims alleging breach of fiduciary duties by Hillhaven directors. Management believes these actions are without merit and does not expect a material adverse effect on financial position.
• Regulatory Risk: Ongoing congressional proposals to reduce Medicare and Medicaid expenditures pose a risk, as these programs accounted for approximately 58% and 11% of hospital revenues, and 29% and 45% of nursing center revenues, respectively.
• Subsequent Events: In October/November 1995, Vencor redeemed or converted approximately $190 million in convertible debt, issuing roughly 7.26 million shares of common stock. Interest rate swaps were also entered into to fix rates on $400 million of floating debt.

Investor Verification Checklist

• Verify the impact of the pooling-of-interests accounting on historical comparability, as 1994 figures have been restated to include Hillhaven and Nationwide.
• Confirm the sustainability of operating margins by analyzing results excluding the $128.4 million in merger-related charges.
• Review the terms and covenants of the new $1 billion Credit Facility, specifically limitations on additional debt and stock repurchases.
• Monitor the status of the Horizon Healthcare litigation and potential financial exposure from counterclaims.
• Assess the sensitivity of future earnings to potential changes in Medicare and Medicaid reimbursement rates.